What were Kronox Lab Sciences Ltd's latest quarterly results?
Kronox Lab Sciences Ltd's latest quarterly results (Mar 2026) show
- PAT Growth YoY: +26.6%
- Revenue Growth YoY: 0.0%
- Operating Margin: 36.4%
Kronox Lab Sciences Ltd (Speciality Chemicals) — fundamental analysis, earnings data, and key metrics. PE: 20.2. ROE: 26.8%. This stock is not currently in the Nifty 500 momentum outperformers list.
Based on publicly available financial data. This is educational research, not investment advice.
Kronox Lab Sciences Ltd's latest quarterly results (Mar 2026) show
Kronox Lab Sciences Ltd's current PE ratio is 20.2x.
Kronox Lab Sciences Ltd's price-to-book ratio is 4.8x.
Kronox Lab Sciences Ltd's fundamental strength based on key financial ratios
Kronox Lab Sciences Ltd's debt position
Kronox Lab Sciences Ltd's return ratios over recent years
Kronox Lab Sciences Ltd's operating cash flow is positive (FY2026).
Kronox Lab Sciences Ltd's current dividend yield is 0.33%.
Kronox Lab Sciences Ltd's shareholding pattern (Jun 2026)
Kronox Lab Sciences Ltd's promoter holding has remained stable recently.
Kronox Lab Sciences Ltd is an established outperformer with 1 week of consecutive Nifty 500 outperformance.
Based on quantitative research signals, here is why Kronox Lab Sciences Ltd may be worth studying
Kronox Lab Sciences Ltd investment thesis summary:
Kronox Lab Sciences Ltd's forward outlook based on current data signals
The above FAQs are generated from publicly available earnings data and conference call transcripts. This is educational research only. Sector Alpha is not SEBI registered and does not provide investment advice.